Symbiox Investment & Trading Company Ltd

Symbiox Investment & Trading Company Ltd. has announced its 47th Annual General Meeting (AGM) to be held on Monday, September 28, 2026, at 01:30 PM via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The primary agenda includes the adoption of the Annual Financial Statements for the fiscal year ended March 31, 2026, along with the Auditors' and Directors' reports. Additionally, Mrs. Sunita Show, who retires by rotation, will be considered for re-appointment as a Director. The company has also attached its Annual Report for the year ended March 31, 2026.

Symbiox Investment & Trading Company Ltd has announced its 47th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 01:30 PM IST. The meeting will be conducted through Video Conference (VC) / Other Audio-Visual Means (OAVM) in compliance with MCA and SEBI circulars. The Notice of the AGM and the Annual Report for the financial year 2025-26 are being sent electronically to shareholders with registered email addresses. For shareholders whose email addresses are not registered, the company is providing a weblink and path to access the Annual Report on its website, in accordance with Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Symbiox Investment & Trading Company Ltd has announced its 47th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 01:30 PM IST. The meeting will be conducted entirely through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in compliance with recent regulatory circulars. Key agenda items include the adoption of the Annual Financial Statements for the fiscal year ended March 31, 2026, along with the Auditors' and Directors' reports. Additionally, Mrs. Sunita Show, who retires by rotation, will be considered for re-appointment as a Director. The company has provided detailed notes regarding the virtual meeting format, proxy appointment restrictions, and participation guidelines.

Symbiox Investment & Trading Company Limited held a Board of Directors meeting on August 26, 2026. Key decisions included approving the Director Report, Management Discussion analysis, and Corporate Governance Report for FY 2025-26. The company announced the closure of its Register of Members and share transfer books from September 22 to September 28, 2026, for the upcoming Annual General Meeting (AGM). The 47th AGM is scheduled for September 28, 2026, to be held via Video Conferencing/Other Audio-Visual Means. The board also approved remote e-voting facilities for shareholders, with a 'cut off' date of September 21, 2026, and set the e-voting period from September 25 to September 27, 2026. Mr. Akhil Agarwal was appointed as Scrutinizer for the e-voting process.

Symbiox Investment & Trading Company Ltd has announced a Board of Directors meeting scheduled for August 26, 2026. The primary agenda items include the consideration and approval of the Director's Report, Management Discussion Analysis, and Corporate Governance Report for the Financial Year 2025-26. The meeting will also fix dates for the closure of the Register of Members and Transfer books, and determine the schedule for the 47th Annual General Meeting (AGM), including appointing a scrutinizer for e-voting and poll processes. The status of statutory registers will also be reviewed.

Symbiox Investment & Trading Company Ltd announced the outcome of its Board Meeting held on August 12, 2026. The board approved the Unaudited Financial Results for the quarter ended June 30, 2026 (Q1 FY27) and adopted the Auditor's Limited Review Report. No other matters were transacted during the meeting, which commenced at 02:30 PM and concluded at 04:00 PM.

Symbiox Investment & Trading Company Ltd has announced that its Board of Directors will convene on August 12, 2026, at 2:30 PM. The primary agenda item is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. Additionally, the board will review and approve the limited review report for these financial results. The meeting will also address any other business with the chairperson's permission. This announcement is made in compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

Symbiox Investment & Trading Company Ltd has issued a clarification regarding the applicability of Regulation 32 of SEBI (LODR) Regulations, 2015. The company stated that it has not raised any funds through public issue, rights issue, preferential issue, or QIP during the quarter ended June 30, 2026. Consequently, the statement of deviation or variation under Regulation 32 is not applicable to the company for the said period. This filing serves as a confirmation and requires acknowledgment from the exchange.

Symbiox Investment & Trading Company Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The specific date for the Board Meeting to consider these financial results will be communicated separately. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.

Symbiox Investment & Trading Company Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The board also re-appointed Mr. Akhil Agarwal as Secretarial Auditor and Mrs. Shikha Singhal as Internal Auditor for FY 2026-27. The meeting commenced at 1:30 P.M. and concluded at 02:55 P.M.